1. Home
  2. ATEC vs MNKD Comparison

ATEC vs MNKD Comparison

Compare ATEC & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

N/A

Current Price

$9.21

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo MannKind Corporation

MNKD

MannKind Corporation

N/A

Current Price

$4.04

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATEC
MNKD
Founded
1990
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
ATEC
MNKD
Price
$9.21
$4.04
Analyst Decision
Strong Buy
Buy
Analyst Count
11
8
Target Price
$22.00
$8.69
AVG Volume (30 Days)
1.8M
3.7M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
15.04
N/A
EPS
N/A
N/A
Revenue
$101,739,000.00
$348,966,000.00
Revenue This Year
$18.97
$35.81
Revenue Next Year
$16.70
$11.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
22.23
52 Week Low
$6.82
$2.23
52 Week High
$23.29
$6.51

Technical Indicators

Market Signals
Indicator
ATEC
MNKD
Relative Strength Index (RSI) 50.46 50.66
Support Level $8.99 $3.74
Resistance Level $9.57 $4.23
Average True Range (ATR) 0.35 0.15
MACD -0.05 -0.01
Stochastic Oscillator 32.07 38.76

Price Performance

Historical Comparison
ATEC
MNKD

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

Share on Social Networks: